Literature DB >> 11359031

Body fat distribution and total body fat as risk factors for microalbuminuria in the obese.

L Mulyadi1, C Stevens, S Munro, J Lingard, M Bermingham.   

Abstract

BACKGROUND/AIM: Despite evidence linking type of obesity with subsequent organ malfunction, such a link with renal malfunction has not been widely researched. The aim of this study was to investigate percentage of total body fat (%TBF), and body fat distribution in relation to the renal function in overweight/obese subjects.
METHODS: Body mass index (BMI), waist-to-hip ratio (WHR), TBF (by bioelectric impedance), and albumin excretion rate (AER) were determined in 77 subjects: 48 overweight/obese (BMI > or =27.8 for men and > or =27.3 for women) and 29 controls (BMI <27.8 for men and <27.3 for women). Obese subjects were subdivided into those (n = 33) with central fat distribution (WHR > or =0.81 for women and > or =0.92 for men) and those (n = 15) with peripheral fat distribution (WHR <0.81 for women and <0.92 for men).
RESULTS: Obesity, irrespective of type, was significantly related to increased AER. Furthermore, in subjects who did not differ in %TBF, the age-adjusted relative risk of abnormal AER was 18 times greater in centrally obese subjects as compared with controls, while only four times greater in peripherally obese subjects.
CONCLUSION: A significant difference in risk of renal malfunction was observed in individuals having the same %TBF, but differing in the distribution of this fat, with a central fat pattern being the greater risk. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11359031     DOI: 10.1159/000046708

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  11 in total

1.  Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study.

Authors:  Meredith C Foster; Shih-Jen Hwang; Joseph M Massaro; Udo Hoffmann; Ian H DeBoer; Sander J Robins; Ramachandran S Vasan; Caroline S Fox
Journal:  Obesity (Silver Spring)       Date:  2010-12-23       Impact factor: 5.002

2.  Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index.

Authors:  Arjan J Kwakernaak; Dorien M Zelle; Stephan J L Bakker; Gerjan Navis
Journal:  J Am Soc Nephrol       Date:  2013-04-11       Impact factor: 10.121

3.  Gender- and Age-Specific Associations between Visceral Obesity and Renal Function Impairment.

Authors:  Yu-Chung Tsao; Jau-Yuan Chen; Wei-Chung Yeh; Wen-Cheng Li
Journal:  Obes Facts       Date:  2019-02-06       Impact factor: 3.942

Review 4.  Optimizing blood pressure control in the obese patient.

Authors:  Tobias Pischon; Arya M Sharma
Journal:  Curr Hypertens Rep       Date:  2002-10       Impact factor: 5.369

Review 5.  Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk.

Authors:  Francesco Giorgino; Jiten Vora; Peter Fenici; Anna Solini
Journal:  Cardiovasc Diabetol       Date:  2020-11-22       Impact factor: 9.951

6.  U-shaped association between central body fat and the urinary albumin-to-creatinine ratio and microalbuminuria.

Authors:  Kathleen Dittmann; Anke Hannemann; Henri Wallaschofski; Rainer Rettig; Sylvia Stracke; Henry Völzke; Matthias Nauck; Nele Friedrich
Journal:  BMC Nephrol       Date:  2013-04-17       Impact factor: 2.388

7.  Prevalence and determinants of microalbuminuria among diabetic patients in the United Arab Emirates.

Authors:  Fatma Al-Maskari; Mohammed El-Sadig; Enyioma Obineche
Journal:  BMC Nephrol       Date:  2008-01-29       Impact factor: 2.388

8.  The Relationship between Serum Bilirubin and Elevated Fibrotic Indices among HBV Carriers: A Cross-Sectional Study of a Chinese Population.

Authors:  Min Du; Shanshan Zhang; Lin Xiao; Yanyan Xu; Peiyi Liu; Yuhan Tang; Sheng Wei; Mingyou Xing; Xiaoping Miao; Ping Yao
Journal:  Int J Mol Sci       Date:  2016-12-09       Impact factor: 5.923

9.  Association Between Body Mass Index Combined with Albumin: creatinine Ratio and All-cause Mortality in Chinese Population.

Authors:  Jiachuan Xiong; Jinwei Wang; Jinghong Zhao; Luxia Zhang
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

Review 10.  Cardiovascular protection with sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Does it apply to all patients?

Authors:  Francesco Giorgino; Jiten Vora; Peter Fenici; Anna Solini
Journal:  Diabetes Obes Metab       Date:  2020-05-07       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.